Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature
暂无分享,去创建一个
A. Prakash | Abhinav R Jain | R. Desai | A. Aggarwal | Sonali Sachdeva | Udita Gupta | Ankita Aggarwal
[1] Sheng-wei Jin,et al. J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes , 2020, Diabetes Research and Clinical Practice.
[2] A. Maran,et al. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration , 2020, Diabetes Research and Clinical Practice.
[3] L. Ghiadoni,et al. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study , 2020, Diabetes Care.
[4] Wei Wang,et al. Hyperglycemia is a strong predictor of poor prognosis in COVID-19 , 2020, Diabetes Research and Clinical Practice.
[5] Yu Hu,et al. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019 , 2020, Frontiers in Endocrinology.
[6] Feng Wu,et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study , 2020, Diabetologia.
[7] Lihua Lai,et al. Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: A multicenter retrospective cohort study , 2020, Journal of Infection.
[8] A. Brufsky,et al. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19 , 2020, medRxiv.
[9] Q. Lv,et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study , 2020, BMJ open diabetes research & care.
[10] Lulu Chen,et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19 , 2020, Diabetes, obesity & metabolism.
[11] G. Paolisso,et al. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? , 2020, Diabetes Care.
[12] D. Klonoff,et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States , 2020, Journal of diabetes science and technology.
[13] G. Iacobellis,et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes , 2020, Diabetes Research and Clinical Practice.
[14] Hong Zhang,et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan , 2020, Diabetes, obesity & metabolism.
[15] R. Pranata,et al. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[16] A. Brufsky. Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic , 2020, Journal of medical virology.
[17] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[18] C. Midgley,et al. Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia , 2020, Emerging infectious diseases.
[19] K. Nugent,et al. The Effect of Short‐Term Hyperglycemia on the Innate Immune System , 2016, The American journal of the medical sciences.
[20] C. Schumann,et al. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study , 2012, BMJ : British Medical Journal.
[21] Jin-Kui Yang,et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.
[22] R. Testa,et al. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. , 2009, Journal of the American College of Cardiology.
[23] J. Chan,et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[24] Brian H Rowe,et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. , 2005, Diabetes care.
[25] A. Aljada,et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. , 2000, The Journal of clinical endocrinology and metabolism.